Leptin Signaling in Myometrium and Leiomyoma
Corresponding Organization : Johns Hopkins University
Other organizations : Khulna Medical College
Variable analysis
- Leptin treatment (100 ng/mL for 48 h)
- Inhibitor treatments (STAT3 inhibitor AG490 at 50 μM, ERK inhibitor PD98059 at 10 μM, and AKT inhibitor MK2206 at 10 μM for 24 h)
- Protein quantification and analysis of myometrium and leiomyoma cells
- Multiplex array analysis of myometrium and leiomyoma media
- Cell types (primary myometrium, leiomyoma, and human adipocyte (SW872) cells)
- Transwell system with 0.4-mm porous membranes
- Coculture duration (8 days, with 50% medium change every 48 h)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!